T1	intervention 0 13	Oral curcumin
T2	condition 18 38	radiation dermatitis
T3	No-of-participants 62 65	686
T4	control 557 564	placebo
T5	No-of-participants 644 647	686
T6	eligibility 66 88	breast cancer patients
T7	No-of-participants 822 825	686
T8	ethinicity 878 883	white
T9	average-age 904 906	58
T10	outcome 979 1008	radiation dermatitis severity
T11	outcome 1147 1176	trend toward reduced severity
T12	intervention-value 1178 1181	7.4
T13	control-value 1186 1191	12.9%
T14	outcome 1205 1268	Patient-reported changes in pain, symptoms, and quality of life
T15	outcome 1361 1390	radiation dermatitis severity
